LP
SRTAW

LMR Partners’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History

LMR Partners’s Portfolio SRTAW Stock Details SRTAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,031,348
Closed -$196K – 1230
2024
Q3 		$196K Buy
+1,031,348
New +$188K ﹤0.01% 997

Other funds holding SRTAW

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

LMR Partners's SRTAW Position: Q1 2026 in Review

LMR Partners held its Strata Critical Medical Inc Warrants (SRTAW) position steady in Q1 2026 at 1,881,170 shares worth $9.41K. The position accounts for ﹤0.01% of the portfolio, ranked #1372.

LMR Partners first reported a position in SRTAW in Q1 2020 and has held it in 23 quarters since. The position peaked at $5.47M in Q3 2021. 8 funds tracked by Wall St. Rank hold SRTAW as of Q1 2026.

  • LMR Partners held 1,881,170 shares of Strata Critical Medical Inc Warrants worth $9.41K as of Q1 2026.
  • LMR Partners left its Strata Critical Medical Inc Warrants share count unchanged in Q1 2026.
  • Strata Critical Medical Inc Warrants made up ﹤0.01% of LMR Partners's portfolio in Q1 2026, its #1372 holding.
  • LMR Partners first reported a position in Strata Critical Medical Inc Warrants in Q1 2020 and has held it in 23 quarters since.
  • LMR Partners's Strata Critical Medical Inc Warrants position peaked at $5.47M in Q3 2021.
  • 8 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.